Does DABIGATRAN ETEXILATE Cause Unevaluable event? 180 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 180 reports of Unevaluable event have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.5% of all adverse event reports for DABIGATRAN ETEXILATE.
180
Reports of Unevaluable event with DABIGATRAN ETEXILATE
0.5%
of all DABIGATRAN ETEXILATE reports
8
Deaths
82
Hospitalizations
How Dangerous Is Unevaluable event From DABIGATRAN ETEXILATE?
Of the 180 reports, 8 (4.4%) resulted in death, 82 (45.6%) required hospitalization, and 3 (1.7%) were considered life-threatening.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 180 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Unevaluable event Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB